Thomas James Doyle
SVP, Finance & Accounting · Kura Oncology, Inc.
- 2025
- Sep 29, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Thomas James Doyle files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Troy Edward Wilson - $2.35M in KURA purchases and sales in the last 12 months
- Mollie Leoni - $1.52M in KURA purchases and sales in the last 12 months
- Teresa Brophy Bair - $701K in KURA purchases and sales in the last 12 months
- Brian T. Powl - $663K in KURA purchases and sales in the last 12 months
- Francis Burrows - $468K in KURA purchases and sales in the last 12 months
- Kathleen Ford - $225K in KURA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Thomas James Doyle?
Thomas James Doyle is a corporate insider, tracked as SVP, Finance & Accounting of Kura Oncology, Inc. (KURA). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Thomas James Doyle submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Thomas James Doyle been buying or selling stock?
Recorded transactions: 0 open-market purchases and 8 open-market sales ($200K) across all tracked filings.
